ANDA 84955, held by Parke Davis. Sulfisoxazole.
As of Nov 15, 2026, ANDA 84955 (Sulfalar), held by Parke Davis, was first approved by FDA on Jan 5, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 5, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sulfalar500MG ยท tablet;oral | Sulfisoxazole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
